Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 19Ovarian Neoplasms 11Neoplasms 7Liposarcoma 7Leiomyosarcoma 7Neoplasm Metastasis 4Sarcoma, Ewing 3Breast Neoplasms 3Solitary Fibrous Tumors 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Prostatic Neoplasms 2Neoplasms by Site 2Liposarcoma, Myxoid 2Histiocytoma, Malignant Fibrous 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Wilms Tumor 1Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor, Protocol Specific 1Soft Tissue Neoplasms 1Skin Diseases 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Recurrent High Grade Meningioma 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Ovarian Diseases 1

Interventions

Cyclophosphamide 3Trabectedin 2pembrolizumab 1interferon gamma-1b 1fludarabine 1aldesleukin 1Sirolimus 1Pioglitazone 1Interferon-gamma 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Liposarcoma, Myxoid × Trabectedin × Clear all
NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed
10 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT00579501 2014-05-07

Safety and Efficacy Study of Trabectedin for the Treatment of Localized Myxoid / Round Cell Liposarcoma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
29 enrolled 7 charts
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡